Cysteamine derivatives for oral treatment of seborrhea

A method for treating a scalp, characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion of sebum comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with a non-toxic active compound selected from the group consisting of

• 2-methylthio ethylamine cinnamate,
• 2-hexadecylthio ethylamine hydrochloride,
• 2-allylthio ethylamine malate,
• 9-octadecene-2-ylthio ethylamine hydrochloride,
• 2-dodecylthio ethylamine hydrochloride,
• 2-isopentylthio ethylamine mandelate,
• 2-octadecylthio ethylamine salicylate,
• 2-.beta.-hydroxyethylthio ethylamine hydrochloride,
• 2-(2,3-dihydroxy propylthio) ethylamine p-toluenesulfonate,
• 2-(2-hydroxy propylthio) ethylamine oxalate,
• 2-(2,2-dimethoxy ethylthio) ethylamine hydrochloride,
• 2-(2,2-dimethoxy ethylthio) ethylamine undecylenate,
• 2-(2,2-diethoxy ethylthio) ethylamine undecylenate,
• 2-(2,2-diethoxy ethylthio) ethylamine acetate,
• 2-undecenylthio ethylamine,
• 2-.beta.-acetamidoethylthio ethylamine tropate,
• 2,2'-thio diethylamine fumarate,
• 3-.beta.-aminoethylthio propylamine hydrochloride,
• 3-allylthio propylamine,
• 3-(2,2'-dimethoxy ethylthio) propylamine,
• 3-(2,2'-dimethoxy ethyl thio) propylamine sulfate,
• 2-t-butylthio ethylamine hydrochloride,
• 2,2'-thio diethylamine dihydrochloride,
• 2-methylthio ethylamine,
• 2-cetylthio ethylamine hydrochloride,
• 2-methylthio ethylamine phenylacetate and
• 2-methylthio ethylamine undecylenate,
• said active compound being present in an amount ranging from 0.75 to 3 percent by weight of said composition and said composition being administered at a rate of 1-5 mg/kg/day based on the weight of the human being.